Wolfgang Nickl - Bayer AG CFO, Member of the Management Board

BAYZF Stock  USD 20.64  0.18  0.88%   

CFO

Mr. Wolfgang U. Nickl was Chief Financial Officer, Member of the Management Board of Bayer Aktiengesellschaft since June 1, 2018. He was Member of the Management Board at the Company since April 26, 2018. He completed a Bachelor of Business Administration at the University of Cooperative Education Stuttgart in 1992 and obtained a MBA from the Marshall School of Business at the University of Southern California in Los Angeles, United States, in 2005. Starting in 1992, he acquired his first professional experience as a consultant and controller for German IT service provider SerCon. In 1995, he joined Western Digital Corporationrationration, San Jose, California, a manufacturer of hard disk drives and other data storage products. His first roles at this company were as Business Planning Manager in the Netherlands and then as Director Business Solutions in the United States. In 2000, Mr. Nickl was appointed Chief Financial Officer at IT company Converge in the United States. Two years later, he returned to Western Digital where he held a number of finance positions with increasing responsibility. He also headed World Business Operations at this company for a number of years before being promoted to Chief Financial Officer in 2010. In December 2013, Mr. Nickl joined ASML N.V. in the Netherlands as Executive Vice President and Chief Financial Officer. since 2018.
Age 54
Tenure 6 years
Professional MarksMBA
Phone49 214 30 1
Webhttps://www.bayer.com

Bayer AG Management Efficiency

The company has return on total asset (ROA) of 0.0576 % which means that it generated a profit of $0.0576 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.13 %, meaning that it generated $0.13 on every $100 dollars invested by stockholders. Bayer AG's management efficiency ratios could be used to measure how well Bayer AG manages its routine affairs as well as how well it operates its assets and liabilities.
Bayer AG has accumulated 35.55 B in total debt with debt to equity ratio (D/E) of 1.17, which is about average as compared to similar companies. Bayer AG has a current ratio of 1.16, suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due. Debt can assist Bayer AG until it has trouble settling it off, either with new capital or with free cash flow. So, Bayer AG's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bayer AG sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bayer to invest in growth at high rates of return. When we think about Bayer AG's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 4 records

CFO Age

David CPATitan International
56
Neal CPAKaiser Aluminum
65
Kelly SteckelbergZoom Video Communications
56
Thomas CPAIridium Communications
66
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. Bayer Ag is traded on OTC Exchange in the United States. Bayer AG [BAYZF] is a Pink Sheet which is traded between brokers over the counter.

Management Performance

Bayer AG Leadership Team

Elected by the shareholders, the Bayer AG's board of directors comprises two types of representatives: Bayer AG inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bayer. The board's role is to monitor Bayer AG's management team and ensure that shareholders' interests are well served. Bayer AG's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bayer AG's outside directors are responsible for providing unbiased perspectives on the board's policies.
Sarena Lin, Labor Officer
Oliver Maier, Head Relations
Gabriel Harnier, Patents Law
Heiko Schipper, Member of the Management Board, Head of the Consumer Health Division
Rodrigo Santos, Member Division
Michael Preuss, Gov Communications
Stefan Oelrich, Member of the Management Board, Head of the Pharmaceuticals Division
Wolfgang Nickl, CFO, Member of the Management Board
BerndPeter Bier, Head Taxes
Werner Baumann, Chief Strategy and Portfolio Officer and Member of Management Board

Bayer Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Bayer AG a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Bayer Pink Sheet

Bayer AG financial ratios help investors to determine whether Bayer Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bayer with respect to the benefits of owning Bayer AG security.